Teva agrees to pay $225M in fines to settle DOJ charges of price-fixing generic drugs
Teva Pharmaceuticals $TEVA is doling out $225 million in fines over the next five years after it came to an agreement with the US Department …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
